Propafenone Hydrochloride Extended-Release Capsules recall
FDA recall D-0352-2025 · initiated Mar 13, 2025
Glenmark Pharmaceuticals Inc., USA recalled Propafenone Hydrochloride Extended-Release Capsules in Mar 2025 — an FDA Class II recall (D-0352-2025) because CGMP Deviations.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
CGMP Deviations
The manufacturing process itself
The FDA found the process itself out of compliance, usually before any defective product was identified.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: N/A
Details
- Product
- Propafenone Hydrochloride Extended-Release Capsules, USP 325mg,60-count bottles, Rx Only, Mfd for: Northstar Rx LLC, Memphis, TN 38141, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India. NDC# 16714-826-01
- Recalling company
- Glenmark Pharms
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- U.S. Nationwide
- Initiated
- Mar 13, 2025
- FDA report date
- Apr 16, 2025
Frequently asked
- Was Propafenone Hydrochloride Extended-Release Capsules recalled?
- Glenmark Pharmaceuticals Inc., USA recalled Propafenone Hydrochloride Extended-Release Capsules in Mar 2025 — an FDA Class II recall (D-0352-2025) because CGMP Deviations. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Propafenone Hydrochloride Extended-Release Capsules recalled?
- Per the FDA enforcement record, the reason for recall D-0352-2025 was: CGMP Deviations
- Is a recalled Propafenone Hydrochloride Extended-Release Capsules dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Propafenone Hydrochloride Extended-Release Capsules are affected?
- Distributed: U.S. Nationwide. The recall covers these lots — Lot # 17230767, exp. date Mar-25. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0352-2025.